Financhill
Back

Outlook Therapeutics Quote, Financials, Valuation and Earnings

Sell
44

OTLK
Outlook Therapeutics

Last Price:
7.78
Seasonality Move:
22.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Outlook Therapeutics Price Quote

$7.78

Outlook Therapeutics Key Stats

Sell
44
Outlook Therapeutics (OTLK) is a Sell

Day range:
$7.18 - $7.92
52-week range:
$4.00 - $40.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
12.69
P/B ratio:
0%

Volume:
185.1K
Avg. volume:
265.5K
1-year change:
-67.58%
Market cap:
$181.3M
Revenue:
$0
EPS:
$-11.41

How Much Does Outlook Therapeutics Make?

Data Unavailable

Is Outlook Therapeutics Growing As A Company?

Data Unavailable

Outlook Therapeutics Stock Price Performance

What Is Outlook Therapeutics 52-Week High & Low?

Outlook Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Outlook Therapeutics?

Is Outlook Therapeutics Cash Flow Positive?

  • What Is OTLK Cash Flow From Operations?
    Cash flow from operations (TTM) is -$58.3M
  • What Is Outlook Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $61.9M
  • What Is Outlook Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Outlook Therapeutics Return On Invested Capital

Data Unavailable

Outlook Therapeutics Earnings Date & Stock Price

Outlook Therapeutics Competitors

Outlook Therapeutics Dividend Yield

Data Unavailable

Outlook Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -43.79%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 39.86
Upside from Last Price: 412.3%

Major Shareholders

  • How many OTLK shares are owned by institutional investors?
    56.6M OTLK shares are owned by institutional investors
  • How many OTLK shares are owned by insiders?
    10.6M OTLK shares are owned by insiders